This study is designed to evaluate the safety and tolerability of a single dose of an investigational drug, alogliptin, in children and adults with type 2 diabetes.

Eligibility Requirements

To qualify for this clinical trial, you must meet the following eligibility requirements:

• Be between 10 to 17 years old or between 18 and 65 years old
• Have a diagnosis of type 2 diabetes

Study Requirements

Participation requires one or two screening visits, a three-day, two-night stay, and two follow-up outpatient visits.

The study will take place at the Duke Clinical Research Unit.

Compensation

Participants will receive payment for time and travel.

For more information, contact Duke Clinical Research Unit at 919-613-6246.